Evidence map›Paper›PMID 41751890›Full record

ArticleInternational journal of molecular sciences2026

In Vitro and Clinical Evaluation of the Anti-Wrinkle Efficacy of Medipep-6PN, a Novel Peptide Identified by Phage Display.

Jinho Bang, Kyuhyuk Im, Yul-Lye Hwang, Mi Yoon Kim, Jae Nam Yun, Min Youl Chang, Sunghyun Kim, Jeung-Hoon Lee

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jinho BangSKINMED R&D Center, Daejeon 34037, Republic of Korea.
Kyuhyuk ImBio-Healthcare Materials Center, Korea Institute of Ceramic Engineering and Technology, Cheongju 28160, Republic of Korea.
Yul-Lye HwangSKINMED R&D Center, Daejeon 34037, Republic of Korea.
Mi Yoon KimSKINMED R&D Center, Daejeon 34037, Republic of Korea.ORCID 0000-0002-1720-2720
Jae Nam YunSKINMED R&D Center, Daejeon 34037, Republic of Korea.
Min Youl ChangSKINMED Clinical Trials Center, Daejeon 34050, Republic of Korea.
Sunghyun KimBio-Healthcare Materials Center, Korea Institute of Ceramic Engineering and Technology, Cheongju 28160, Republic of Korea.
Jeung-Hoon LeeSKINMED R&D Center, Daejeon 34037, Republic of Korea.

Funding

Ministry of SMEs and Startups S3381597
6 · The paper itself

Abstract

Face wrinkles caused by skin aging can be classified into dynamic wrinkles, which are caused by repetitive contraction of facial expression muscles, and static wrinkles, which are related to extracellular matrix damage and collagen breakdown caused by ultraviolet and oxidative stress. These two mechanisms are closely related, and prolonged, repetitive muscle contractions act as mechanical stress that promotes extracellular matrix degradation within the dermis, accelerating wrinkle formation. In this study, we used phage display to develop a novel peptide, Medipep-6PN, that targets both muscle-type nicotinic acetylcholine receptor (muscle nAChR), a major cause of dynamic wrinkles, and matrix metalloproteinase-1 (MMP-1), a cause of static wrinkles. In this study, the kinetic analysis of Medipep-6PN using surface plasmon resonance analysis showed that the equilibrium dissociation constant (

Indexed as

PeptidesSkin AgingCell LineFemaleFibroblastsHumansMatrix Metalloproteinase 1Middle AgedPeptide LibraryReceptors, NicotinicMatrix Metalloproteinase 1Peptide LibraryPeptidesReceptors, Nicotinicanti-wrinkleclinical studycollagenmatrix metalloproteinase-1muscle-type nicotinic acetylcholine receptorpeptidephage display

Identifiers

PMID41751890
PMCPMC12940413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.